Background: Since 2012, the World Health Organization has recommended intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT-SP) to prevent malaria-related complications in pregnant women. Ten years following these recommendations, we conducted this study to estimate the coverage for three doses of IPT-SP (IPT3) as well as the prevalence of low birth weight (LBW), and its associated factors in Lomé (Togo) in 2021. Methods: A cross-sectional study was conducted between January and March 2021. An exhaustive recruitment of women and their newborns was carried out in the maternity wards of the Sylvanus Olympio University Hospital Center. Data from antenatal consultations and clinical data of the newborns were collected. Multivariate logistic regression was carried out to determine factors associated with LBW. Results: A total of 252 mother-child pairs were included in this study. Median age of the mothers was 27 years, IQR [24-31]. More than a third (35.3%) of the mothers were primigravida. IPT3 coverage was 66.7% and 14.7% of newborns had a LBW. The prevalence of LBW was 33.3% [23.3-43.4] in women who had received fewer than 3 doses of IPT-SP and 5.4% [2.0-8.8] in those who had received at least 3 doses of IPT-SP (p < 0.001). In multivariable analysis, administration of less than three doses was associated with LBW (aOR = 9.3; 95% CI [4.2-22.3]). Conclusion: Ten years following recommendations of the WHO on IPT-SP, malaria prevention based on IPT-SP is not optimal among pregnant women in Lomé, and the proportion of LBW children remains high. Actions to strengthen the three-dose IPT-SP policy are needed to prevent malaria and its consequences among newborns in Togo.
References
[1]
World Health Organisation (2021) Global Technical Strategy for Malaria 2016-2030, 2021 Update. Genève. https://apps.who.int/iris/?locale-attribute=fr&
[2]
Pilly, E. (2019) Maladies Infectieuses et tropicales: Tous les items d’infectiologie. 27th Edition, Alinéa Plus, Paris.
[3]
Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, Arrow, K.J., Panosian, C. and Gelband, H. (2004) A Brief History of Malaria: Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. National Academies Press, Washington DC. https://www.ncbi.nlm.nih.gov/books/NBK215638/
[4]
World Health Organization (2020) World Malaria Report 2020: 20 Years of Global Progress and Challenges. Geneva. https://apps.who.int/iris/handle/10665/337660
[5]
Organisation Mondiale de la Santé (2021) Rapport 2021 sur le paludisme dans le monde, Données et tendances régionales WHO/UCN/GMP/2021.09. https://cutt.ly/wMRsjjY
[6]
Oumarou, Z.M., Lamine, M.M., Issaka, T., Moumouni, K., Alkassoum, I., Maman, D., et al. (2020) Infection palustre de la femme enceinte à Niamey au Niger. The Pan African Medical Journal, 37, Article 365. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992404/ https://doi.org/10.11604/pamj.2020.37.365.20034
[7]
Douamba, Z., Bisseye, C., Djigma, F.W., Compaoré, T.R., Bazie, V.J., Pietra, V., Nikiema, J.B. and Simpore, J. (2012) Asymptomatic Malaria Correlates with Anaemia in Pregnant Women at Ouagadougou, Burkina Faso. BioMed Research International, 2012, Article ID: 198317. https://doi.org/10.1155/2012/198317
[8]
Fried, M. and Duffy, P.E. (2017) Malaria during Pregnancy. Cold Spring Harbor Perspectives in Medicine, 7, a025551. https://doi.org/10.1101/cshperspect.a025551
[9]
Tako, E.A., Zhou, A., Lohoue, J., et al. (2005) Risk Factors for Placental Malaria and Its Effect on Pregnancy Outcome in Yaounde, Cameroon. The American Journal of Tropical Medicine and Hygiene, 72, 236-242. https://doi.org/10.4269/ajtmh.2005.72.236
[10]
Luhete, P.K., Mukuku, O. and Kayamba, P.K. (2015) Etude du faible poids de naissance associé à l’age maternel et la parité dans une population couple mère-enfant suivi à Lubumbashi [Study of Low Birth Weight Associated with Maternal Age and Parity in a Population of Mother and Children in Lubumbashi]. The Pan African Medical Journal, 20, Article 246. https://doi.org/10.11604/pamj.2015.20.246.5169
[11]
Kabore, P., Donnen, P. and Dramaix, M. (2007) Facteurs de risque obstétricaux du petit poids de naissance à terme en milieu rural sahélien. Santé Publique, 19, 489-497. https://doi.org/10.3917/spub.076.0489
[12]
Savadogo, L.G.B., Ouédraogo, P., Ilboudo, B., Sombié, I., Meda, C., Dramaix, M. and Donnen, P. (2016) Impact du faible poids de naissance sur la croissance, le développe-ment psychomoteur et la morbidité, Bobo-Dioulasso, Burkina Faso. Revue d’Épidé-miologie et de Santé Publique, 64, S254. https://doi.org/10.1016/j.respe.2016.06.305
[13]
World Health Organization (2012) WHO Evidence Review Group: Intermittent Preventive Treatment of Malaria in Pregnancy (IPTp) with Sulfadoxine-Pyrimethamine (SP). WHO Headquarters, Geneva, 9-11 July 2012. Meeting Report. Geneva. http://www.who.int/malaria/mpac/sep2012/iptp_sp_erg_meeting_report_july2012.pdf
[14]
Kayentao, K., et al. (2013) Intermittent Preventive Therapy for Malaria during Pregnancy Using 2 VS 3 or More Doses of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in Africa: Systematic Review and Meta-Analysis. Journal of the American Medical Association, 309, 594-604. https://doi.org/10.1001/jama.2012.216231
[15]
Sirima, S.B., Cotte, A.H., Konaté, A., Moran, A.C., Asamoa, K., Bougouma, E.C., et al. (2006) Malaria Prevention during Pregnancy: Assessing the Disease Burden One Year after Implementing a Program of Intermittent Preventive Treatment in Koupela District, Burkina Faso. The American Journal of Tropical Medicine and Hygiene, 75, 205-211. https://doi.org/10.4269/ajtmh.2006.75.205
[16]
Hommerich, L., von Oertzen, C., Bedu-Addo, G., Holmberg, V., Acquah, P.A., Eggelte, T.A., et al. (2007) Decline of Placental Malaria in Southern Ghana after the Implementation of Intermittent Preventive Treatment in Pregnancy. Malaria Journal, 6, Article No. 144. https://doi.org/10.1186/1475-2875-6-144
[17]
Verhoeff, F.H., Brabin, B.J., Chimsuku, L., Kazembe, P., Russell, W.B. and Broadhead, R.L. (1998) An Evaluation of the Effects of Intermittent Sulfadoxine-Pyrimethamine Treatment in Pregnancy on Parasite Clearance and Risk of Low Birthweight in Rural Malawi. Annals of Tropical Medicine & Parasitology, 92, 141-150. https://doi.org/10.1080/00034983.1998.11813273
[18]
Bamba, S., Séré, A., Nikiéma, R., Halidou, T., Thiéba, B., Dao, B., et al. (2013) Traitement préventif intermittent à la sulfadoxine—Pyriméthamine du paludisme chez les femmes enceintes: Efficacité et observance dans deux hôpitaux urbains du Burkina Faso. The Pan African Medical Journal, 14, Article 105. https://doi.org/10.11604/pamj.2013.14.105.1331
[19]
Shulman, C.E., Marshall, T., Dorman, E.K., Bulmer, J.N., Cutts, F., Peshu, N., et al. (2001) Malaria in Pregnancy: Adverse Effects on Haemoglobin Levels and Birthweight in Primigravidae and Multigravidae. Tropical Medicine & International Health, 6, 770-778. https://doi.org/10.1046/j.1365-3156.2001.00786.x
[20]
McCarthy, K.J., Braganza, S., Fiori, K., Gbeleou, C., Kpakpo, V., Lopez, A., et al. (2017) Identifying Inequities in Maternal and Child Health through Risk Stratification to Inform Health Systems Strengthening in Northern Togo. PLOS ONE, 12, e0173445. https://doi.org/10.1371/journal.pone.0173445
[21]
World Health Organization (2023) Global Burden of Disease. https://data.who.int/fr/indicators/i/AC597B1
[22]
Cutland, C.L., Lackritz, E.M., Mallett-Moore, T., Bardají, A., Chandrasekaran, R., Lahariya, C., et al. (2017) Low Birth Weight: Case Definition & Guidelines for Data Collection, Analysis, and Presentation of Maternal Immunization Safety Data. Vaccine, 35, 6492-6500. https://doi.org/10.1016/j.vaccine.2017.01.049
[23]
Rijken, M., Rijken, J., Papageorghiou, A., Kennedy, S., Visser, G., Nosten, F., et al. (2011) Malaria in Pregnancy: The Difficulties in Measuring Birthweight. BJOG: An International Journal of Obstetrics & Gynaecology, 118, 671-678. https://doi.org/10.1111/j.1471-0528.2010.02880.x
[24]
Hosmer, D.W. and Lemeshow, S. (2013) Apply Logistic Regression. Wiley-Blackwell, New York. https://doi.org/10.1002/9781118548387
[25]
Lingani, M., Zango, S.H., Valéa, I., Somé, G., Sanou, M., Samadoulougou, S.O., et al. (2022) Low Birth Weight and Its Associated Risk Factors in a Rural Health District of Burkina Faso: A Cross Sectional Study. BMC Pregnancy Childbirth, 22, Article No. 228. https://doi.org/10.1186/s12884-022-04554-w
[26]
Biaou, C.O.A., Kpozehouen, A., Glèlè-Ahanhanzo, Y., Ayivi-Vinz, G., Ouro-Koura, A.R. and Azandjèmé, C. (2019) Traitement préventif intermittent à la sulfadoxine-pyriméthamine chez la femme enceinte et effet sur le poids de naissance du bébé: Application de la politique à 3 doses en zone urbaine au Sud Bénin en 2017. The Pan African Medical Journal, 34, Article155. https://doi.org/10.11604/pamj.2019.34.155.19357
[27]
Vanga-Bosson, H.A., Coffie, P.A., Kanhon, S., Sloan, C., Kouakou, F., Eholie, S.P., et al. (2011) Coverage of Intermittent Prevention Treatment with Sulphadoxine-Pyrime-thamine among Pregnant Women and Congenital Malaria in Côte D’Ivoire. Malaria Journal, 10, Article No. 105. https://doi.org/10.1186/1475-2875-10-105
[28]
Ela, M.E., Cumber, S.N., Dakenyo, R.D., Tekam, D.D., Heumou, P.C.B., Marvin, G.L., et al. (2019) Association entre le paludisme et le faible poids de naissance à Yaoundé, Cameroun. The Pan African Medical Journal, 33, Article 127. https://doi.org/10.11604/pamj.2019.33.127.18101
[29]
Tessema, Z.T., Tamirat, K.S., Teshale, A.B. and Tesema, G.A. (2021) Prevalence of Low Birth Weight and Its Associated Factor at Birth in Sub-Saharan Africa: A Generalized Linear Mixed Model. PLOS ONE, 16, e0248417. https://doi.org/10.1371/journal.pone.0248417
[30]
Erasun, D., Alonso-Molero, J., Gómez-Acebo, I., et al. (2021) Faible poids à la naissance des tendances de l’Organisation de Coopération et de Développement économique des pays, 2000-2015: L’économique, le système de santé et démogra-phiques des conditionnements. BMC Pregnancy and Childbirth, 21, Article No. 13. https://doi.org/10.1186/s12884-020-03484-9
[31]
COSMIC Consortium (2019) Community-Based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-Randomized Controlled Trial. Clinical Infectious Diseases, 68, 586-596. https://doi.org/10.1093/cid/ciy522
[32]
Afanvi, K., Viagbo, K. and Djadou, K. (2022) Impact du traitement préventif intermittent du paludisme à la sulfadoxine-pyrimethamine chez la femme enceinte sur le faible poids de naissance dans le district sanitaire des Lacs au Togo de 2004 à 2010. Journal de la Recherche Scientifique de l’Université de Lomé, 24, 371-390.
